Tuesday, December 27, 2011

Delcath Systems, Inc. (DCTH) Achieves Key Milestone with J.W. Goethe Hospital Partnership

Delcath Systems Inc., a development stage specialty pharmaceutical and medical device company focused on oncology, has entered into an initial launch and training agreement with Johann Wolfgang Goethe University Hospital (J.W. Goethe), representing a significant step in Delcath’s progress toward EU market expansion.

J.W. Goethe is a premier European cancer treatment and research center located in Frankfurt, Germany. Per the agreement, Delcath will provide J.W. Goethe with logistics and clinical training support for the Delcath Hepatic CHEMOSAT® delivery system.

“Our team is excited to bring use of the CHEMOSAT system to Germany. Clinical research suggests that chemosaturation therapy using the CHEMOSAT system will offer us a clinically significant tool in treating liver metastases with melphalan. We’re eager to begin providing therapy to our patients and exploring the additional potential benefits that the newest generation product from Delcath provides,” University Professor Dr. Thomas J. Vogl, director of the Institute for Diagnostic and Interventional Radiology at J.W. Goethe, stated in the press release.

Delcath said it expects to begin the training using the Generation Two version of the CHEMOSAT system, pending CE Mark approval. The company expects to begin raining at the J.W. Goethe University Hospital in February 2012.

“This agreement marks another key milestone in the execution of our commercialization strategy for the CHEMOSAT system in the European Union,” Eamonn P. Hobbs, president and CEO of Delcath stated. “Germany is the largest market in the EU and we are excited to be entering it with a partner as prestigious as J.W. Goethe. CHEMOSAT will be available to patients in Germany soon, and this latest agreement further positions us to begin realizing the system’s potential throughout Europe in 2012.”

For more information visit www.delcath.com

About QualityStocks:

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: